[In vitro antimicrobial activity of CI-919 against gram-negative bacilli and Staphylococcus aureus isolated from various pathologies].
D000328:Adult; D000617:Aminoglycosides / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002648:Child; D004352:Drug Resistance, Microbial; D015365:Enoxacin; D006090:Gram-Negative Bacteria / Q000187:drug effects*; D006801:Humans; D066298:In Vitro Techniques; D007769:Lactams; D008826:Microbial Sensitivity Tests; D009287:Naphthyridines / Q000494:pharmacology*; D013211:Staphylococcus aureus / Q000187:drug effects*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D007769:Lactams; D009287:Naphthyridines; D015365:Enoxacin
Actividad antimicrobiana in vitro del CI-919 frente a bacilos gram negativos y Staphylococcus aureus aislados de diversas patologías.